bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 8, 2023
Abstract
The
continual
emergence
of
new
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
variants
challenges
available
SARS-CoV-2
vaccines
for
adequate
control
outbreaks.
Currently,
universal
capable
obviating
the
need
exact
strain
matching
between
mRNA
and
circulating
viruses
are
absent.
In
this
study,
we
designed,
manufactured,
evaluated
a
nucleoside-modified
lipid
nanoparticle
vaccine,
aimed
offering
broad-spectrum
protection
against
recent
variants.
Additionally,
efficiency
monovalent,
bivalent,
quadrivalent,
XBB.1.5
was
compared
with
proposed
vaccine.
neutralizing
antibody
activity
wuhan-1,
BA.4/5,
XBB.1.5,
B.1.1.529,
BQ.1.1,
EG.5.1
JN.1
assessed
using
enzyme-linked
immunosorbent
assay,
rapid
fiber-optic
biolayer
interferometry-based
biosensor,
pseudovirus
neutralization
test.
Our
results
reveal
that
multivalent
vaccine
affords
comprehensive
previously
circulating,
current
unidentified
strains.
Biosensors,
Journal Year:
2023,
Volume and Issue:
13(9), P. 851 - 851
Published: Aug. 26, 2023
Here,
we
report
magnetic
nanoparticle-based
biosensor
platforms
for
the
rapid
detection
of
SARS-CoV-2
antibody
responses
in
human
serum.
The
use
proposed
system
enabled
anti-SARS-CoV-2
spike
(S)
and
nucleocapsid
(N)
proteins
at
a
concentration
ng/mL
both
buffer
real
serum
samples.
In
particular,
protocol,
which
is
considered
an
indicator
innate
immunity
after
vaccination
or
post-infection,
could
be
useful
evaluation
response.
We
included
total
48
volunteers
who
either
had
COVID-19
but
were
not
vaccinated
with
CoronoVac
Biontech.
Briefly,
this
study,
was
planned
as
cohort,
samples
examined
3,
6,
12
months
from
time
volunteers'
showed
symptoms
respect
to
response
system.
Anti-S
Ab
anti-N
detected
limit
0.98
0.89
ng/mL,
respectively.
These
data
confirmed
corresponding
commercial
electrochemiluminescence
immunoassay
(ECLIA)
assays.
Compared
ECLIA,
more
stable
obtained,
especially
collected
over
6
months.
After
period,
drop
observed.
Our
findings
that
it
platform
exploring
dynamics
immune
response,
has
translational
potential
clinic.
conclusion,
MNP-based
together
its
counterparts
previous
studies,
candidate
determining
natural
post-vaccination
well
reducing
workload
medical
personnel
paving
way
screening
studies
on
vaccine
efficacy.
Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
95(27), P. 10322 - 10329
Published: June 20, 2023
The
level
of
25-hydroxyvitamin
D3
[25(OH)VD3]
in
human
blood
is
considered
as
the
best
indicator
vitamin
D
status,
and
its
deficiency
or
excess
can
lead
to
various
health
problems.
Current
methods
for
monitoring
25(OH)VD3
metabolism
living
cells
have
limitations
terms
sensitivity
specificity
are
often
expensive
time-consuming.
To
address
these
issues,
an
innovative
trident
scaffold-assisted
aptasensor
(TSA)
system
has
been
developed
online
quantitative
complex
biological
environments.
Through
computer-aided
design,
TSA
includes
aptamer
molecule
recognition
layer
that
uniformly
oriented,
maximizing
binding
site
availability,
enhancing
sensitivity.
achieved
direct,
highly
sensitive,
selective
detection
over
a
wide
concentration
range
(17.4–12,800
nM),
with
limit
17.4
nM.
Moreover,
we
evaluated
efficacy
biotransformation
liver
cancer
(HepG2)
normal
(L-02),
demonstrating
potential
platform
drug–drug
interaction
studies
candidate
drug
screening.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 26, 2024
Knowledge
on
the
antibody
response
to
inactivated
vaccines
in
third
dose
is
crucial
because
it
one
of
primary
global
vaccination
programs.
This
study
integrated
microsampling
with
optical
biosensors
profile
neutralizing
antibodies
(NAbs)
fifteen
vaccinated
healthy
donors,
followed
by
application
machine
learning
predict
at
given
timepoints.
Over
a
nine-month
duration,
and
venipuncture
were
conducted
seven
individual
A
refined
iteration
fiber
optic-biolayer
interferometry
(FO-BLI)
biosensor
was
designed,
enabling
rapid
multiplexed
biosensing
NAbs
towards
both
wild-type
Omicron
variants
minutes.
Findings
revealed
strong
correlation
(Pearson
r
0.919,
specificity
100%)
between
levels
microsamples
sera.
Following
dose,
Sera
for
wide-type
increased
2.9-fold
after
days
3.3-fold
within
month,
subsequently
waning
becoming
undetectable
three
months.
Considerable
but
incomplete
escape
latest
omicron
subvariants
from
booster
vaccine
elicited
confirmed,
although
higher
number
binding
(BAbs)
identified
another
FO-BLI
Significantly,
highly
correlated
pseudovirus
neutralization
assay
identifying
capacities
0.983).
Additionally,
demonstrated
exceptional
accuracy
predicting
an
error
<5%
BAbs
across
multiple
Microsample-driven
enables
individuals
access
their
results
hours
self-collection,
while
precise
models
could
guide
personalized
strategies.
The
technology's
innate
adaptability
positions
its
potential
effective
translation
diseases
prevention
development.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 8, 2023
Abstract
The
continual
emergence
of
new
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
variants
challenges
available
SARS-CoV-2
vaccines
for
adequate
control
outbreaks.
Currently,
universal
capable
obviating
the
need
exact
strain
matching
between
mRNA
and
circulating
viruses
are
absent.
In
this
study,
we
designed,
manufactured,
evaluated
a
nucleoside-modified
lipid
nanoparticle
vaccine,
aimed
offering
broad-spectrum
protection
against
recent
variants.
Additionally,
efficiency
monovalent,
bivalent,
quadrivalent,
XBB.1.5
was
compared
with
proposed
vaccine.
neutralizing
antibody
activity
wuhan-1,
BA.4/5,
XBB.1.5,
B.1.1.529,
BQ.1.1,
EG.5.1
JN.1
assessed
using
enzyme-linked
immunosorbent
assay,
rapid
fiber-optic
biolayer
interferometry-based
biosensor,
pseudovirus
neutralization
test.
Our
results
reveal
that
multivalent
vaccine
affords
comprehensive
previously
circulating,
current
unidentified
strains.